About 67 Trademarks found for “ARENA*”

Ankle boots; Belts for clothing; Blouses; Boots; Coats; Dress suits; Dresses; casual shoes; Hats; Headbands; Headgear, namely, hats and caps; Heels; Jackets; Jeans; Lace boots; Leggins; Mules; Pants; Sandals; Shirts; Shoes; Short-sleeved shirts; Skirts; Skorts; Skull caps; Slips; Socks; Stockings; Sweaters; T-shirts; Trousers; Underclothes; Undershirts; Vests; Wooden shoes.

Cleaning of ice arena area including dash boards.

Pharmaceutical preparations and pharmaceutical compounds for the treatment of metabolic disorders.

Scientific and technological services, namely, medical laboratories; scientific research, studies, and development for others in the field of pharmaceuticals; scientific research and development for others, namely, pharmaceutical discovery, pharmaceutical screening assay development and studies, structure activity relationship studies, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation development; conducting and evaluating clinical trials.

Tractor towed implements for grooming, tilling, and plowing equine areas.

Chemicals for use in the manufacture of insecticides, fungicides and herbicides.

Insecticides, fungicides, herbicides, and preparations for killing weeds and destroying vermin.

Pharmaceutical preparations for the treatment of obesity, diabetes, sleep disorders, insomnia, thrombosis, platelet aggregation, dyslipidemia, atherosclerosis, insulin resistance, anxiety, depression, drug and alcohol addiction, psychotic disorders, dementia, coronary artery disease, myocardial infarction, vasoconstriction, intimal hyperplasia, arterial thrombo-embolic disease, acute coronary syndrome, atheromatous disease, hypertension, transient ischemic attack, angina, stroke, heart disease, atrial fibrillation, progressive multifocal leukoencephalopathy, inadequate glucose tolerance, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, and syndrome X; pharmaceutical preparations for the promotion of weight loss, sleep, sleep maintenance, sleep consolidation, increased levels of HDL, and reduction in the risk of blood clot formation.

Chemicals and chemical compounds, namely, those for use in biotechnology, drug discovery and the manufacture and development of pharmaceuticals for the treatment of metabolic disorders, and cardiovascular disorders; chemicals and chemical compounds, namely, those for use in biotechnology, drug discovery and the manufacture and development of pharmaceuticals for the treatment of disorders of the central nervous system, namely, spinal cord injury, pain including neuropathic pain, cerebral infarction, agitation or a symptom thereof, behavioral disorders, psychosis including drug induced psychosis, excitative psychosis, and organic or NOS psychosis, Gilles de la Tourette's syndrome, manic disorder, psychotic disorder, schizophrenia including acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, anxiety, depression, obsessive compulsive disorders, eating disorders, suicide, migraine, emesis, alcoholism, neurodegenerative disorders, autism including infantile autism, Huntington’s chorea, mood disorders, anxiety disorders, panic disorders, alcoholism, cerebral degenerative disorders, dementia, parkinsonism, fatal familial insomnia, bipolar disorders, social phobias, sexual dysfunction, personality disorder, premenstrual tension, epilepsy including sleep-related epilepsy, electrical status epilepticus of sleep, benign focal epilepsy of childhood, benign Rolandic epilepsy, childhood absence epilepsy, frontal lobe epilepsy, and temporal lobe epilepsy, addiction, neurodegenerative diseases including Alzheimer’s disease, arousal disorders, catatonia, cognitive dysfunction, hallucinations including auditory hallucinations and hypnagogic hallucinations, psychomotoric disorders, stress, attention deficit hyperactivity disorder, brain trauma, cataplexy, delusions, disorganization syndrome, infantile spasms, itch, Lennox-Gastaut syndrome, sleep disorders including dyssomnia, psychophysiological insomnia, sleep state misperception, idiopathic insomnia, obstructive sleep apnea syndrome, central sleep apnea syndrome, central alveolar hypoventilation syndrome, periodic limb movement disorder, restless leg syndrome, environmental sleep disorder, altitude insomnia, adjustment sleep disorder, insufficient sleep syndrome, limit-setting sleep disorder, sleep-onset association disorder, nocturnal eating or drinking syndrome, hypnotic dependent sleep disorder, stimulant-dependent sleep disorder, alcohol-dependent sleep disorder, toxin-induced sleep disorder, time zone change (jet lag) syndrome, shift work sleep disorder, irregular sleep-wake pattern, delayed sleep phase syndrome, advanced sleep phase syndrome and non-24-hour sleep-wake disorder, parasomnia, confusional arousals, sleepwalking and sleep terrors, rhythmic movement disorder, sleep starts, sleep talking and nocturnal leg cramps, sleep-related headaches, sleeping sickness, nocturnal cardiac ischemia, sleep-related asthma, sleep-related gastroesophageal reflux, post-surgical sleep disorder, circadian rhythm sleep disorder, excessive daytime sleepiness, frequent awakenings, narcolepsy, hypersomnia, somnolence syndrome, wakefulness; chemicals and chemical compounds, namely, those for use in biotechnology, drug discovery and the manufacture and development of pharmaceuticals for the treatment of inflammatory and auto immunity disorders, namely, transplant rejection, multiple sclerosis, systemic lupus erythematosus, type I diabetes and related disorders, sepsis, microbial infections or diseases and viral infections or diseases, autoimmune myocarditis, acute viral myocarditis, inflammatory bowel disease including colitis, Crohn’s disease and ulcerative colitis, progressive mesangioproliferative glomerulonephritis, asthma including allergic asthma, airway inflammation and induction of bronchial hyperresponsiveness, allergies, allergic rhinitis and allergic responses in the upper airway, atopic dermatitis, autoimmune uveitis, rejection of cells, tissue or solid organ grafts, autoimmune myasthenia gravis, rejection of cells, arthritis including psoriatic arthritis and rheumatoid arthritis, inflammatory skin disease including psoriasis, atopic dermatitis, hyperproliferative skin disease including acne, uveitis, brain inflammation including Alzheimer’s disease and brain inflammatory reaction following traumatic brain or spinal cord injury, gastritis, polymyositis, thyroiditis, vitiligo, hepatitis, biliary cirrhosis, progressive multifocal leukoencephalopathy, fibromyalgia, platelet aggregation.

Laboratory research services involving G Protein Coupled Receptors (GPCRs), and screening of GPCRs for the evaluation, development and clinical testing of compounds identified using GPCRs.

Pesticides, insecticides, fungicides, herbicides; all for use in agriculture, horticulture, silviculture and home and garden.

Construction and building renovation, construction planning, architectural design.

Construction and building renovation, construction planning, architectural design.